Merck is discussing the study data with regulators worldwide, with a goal of making the treatment available for infants as early as the 2025 to 2026 RSV season.
Related Posts
Pfizer tops earnings estimates as Covid product sales beat expectations and cost cuts pay off
The results cap off a critical year for Pfizer, which has been slashing costs as it recovers from the rapid decline of its Covid business […]
Trump appointed judge Aileen Cannon refuses to recuse from attempted assassination case
Judge Aileen Cannon rejected arguments by lawyers for Ryan Routh that she step off the case because she could be seen as partial toward Donald […]
Job openings see gains in January in a sign of labor market stability
The Job Openings and Labor Turnover Survey showed that postings rose to 7.74 million on the month, up 232,000 from December.